Cargando…
Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection
Coronavirus disease 2019 (COVID-19) is a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is defined by respiratory symptoms, but cardiac complications including viral myocarditis are also prevalent. Although ischemic and inflammatory responses caused by COVI...
Autores principales: | Sharma, Arun, Garcia, Gustavo, Wang, Yizhou, Plummer, Jasmine T., Morizono, Kouki, Arumugaswami, Vaithilingaraja, Svendsen, Clive N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323681/ https://www.ncbi.nlm.nih.gov/pubmed/32835305 http://dx.doi.org/10.1016/j.xcrm.2020.100052 |
Ejemplares similares
-
Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020) -
The Utilisation of Hydrogels for iPSC-Cardiomyocyte Research
por: Patel, Leena, et al.
Publicado: (2023) -
Recent advances in human iPSC-derived models of the blood–brain barrier
por: Workman, Michael J., et al.
Publicado: (2020) -
Metabolic Maturation Increases Susceptibility to Hypoxia-induced Damage in Human iPSC-derived Cardiomyocytes
por: Peters, Marijn C, et al.
Publicado: (2022) -
Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction
por: Rojas, Sebastian V., et al.
Publicado: (2017)